Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Point Care. 2010 Mar 1;9(1):36–46. doi: 10.1097/POC.0b013e3181d2d8cc

Table 6.

Score currently available STI tests on ASSURED criteria.

STI Test Affordable Sensitive Specific User-
friendly
Rapid
and
Robust
Equipment-
free
Delivered Total
ASSURED
Score
HIV OraQuick
ADVANCE
0 3 3 1 1 2 1 11
Uni-Gold
Recombigen
1 3 3 1 1 1 1 11
Reveal NA 3 3 0 0 1 1 8
Multispot NA 3 3 0 0 1 1 8
Clearview
Stat-Pak
0 3 3 1 1 1 1 10
Trichomoniasis Wet Mount 3 0 3 0 1 1 1 9
OSOM 1 2 3 1 1 2 1 11
Affirm VPIII 2* 1 3 0 0 0 1 7
Chlamydia BioStar NA 0 3 0 0 0 1 4
Clearview NA 0 3 0 0 0 1 4
Quikvue NA 0 3 0 0 0 1 4
CRT 1 1 3 0 0 2 0 7
Gonorrhea BioStar NA 0 3 0 0 0 1 4
PATH NA 1 3 0 1 1 0 6
*

After initial outlay of>$10,000 for machinery.

NA -prices not available on the website

Explanation of Scores. Total score is the sum (range 0–15):

Affordability (cost to purchase a single test): 0 (over $25), 1 ($11–24), 2 ($3-$10), or 3 (under $2).

Sensitivity and Specificity: 0 (under 65%), 1 (66–85%), 2 (83–94%), or 3 (over 95%).

User-friendly: 0 (moderate complexity) or 1 (waived).

Rapid and Robust: 0 (over 20 minutes to perform and/or refrigeration required) or 1 (under 20 minutes to perform and requires no refrigeration).

Equipment–free: 0 (major invasive sample, such as blood draw or pelvic exam), 1 (minor invasive sample, such as finger prick), or 2 (non-invasive sample such as oral, vaginal swab or urine test).

Delivered: 0 (Not FDA cleared/ available) or 1 (FDA cleared/ available for sale).